Abbvie Inc (NYSE:ABBV)

86.44
Delayed Data
As of Nov 12
 +0.78 / +0.91%
Today’s Change
62.66
Today|||52-Week Range
94.98
-6.24%
Year-to-Date
Why Shares of Reata Pharmaceuticals Rocketed More Than 150% in October
Nov 12 / MotleyFool.com - Paid Partner Content
3 Most Important Takeaways From AbbVie's Q3 Results
Nov 02 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks to Buy Right Now
Nov 11 / MotleyFool.com - Paid Partner Content
What Happened in the Stock Market Today
Nov 01 / MotleyFool.com - Paid Partner Content
This Terrific High-Yield Dividend Stock Just Got Even Better
Nov 10 / MotleyFool.com - Paid Partner Content
AbbVie Inc (ABBV) Q3 2019 Earnings Call Transcript
Nov 01 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks Fighting Alzheimers Disease to Own Now
Nov 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close85.66
Today’s open85.60
Day’s range85.55 - 88.28
Volume12,165,927
Average volume (3 months)8,762,156
Market cap$126.0B
Data as of 6:30pm ET, 11/12/2019

Growth & Valuation

Earnings growth (last year)+10.88%
Earnings growth (this year)+12.83%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+16.08%
P/E ratio38.1
Price/Sales4.35
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.20+0.43%
SNYSanofi+0.19+0.41%
GSKGlaxoSmithKline+0.26+0.59%
LLYEli Lilly and Co+0.37+0.33%
Data as of 6:30pm ET, 11/12/2019

Financials

Next reporting dateJanuary 27, 2020
EPS forecast (this quarter)$2.20
Annual revenue (last year)$32.8B
Annual profit (last year)$5.7B
Net profit margin17.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
North Chicago, Illinois

Forecasts